Research map: 40-week repeat-dose toxicity, toxicokinetics, and immunogenicity of efsubaglutide alfa following subcutaneous administration in cynomolgus monkeys

Back to the article

Papers in this map

  1. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1 · Daniel J. Drucker · 2018 · 2131 citations · Cited by this paper
  2. In silico prediction of Ames mutagenicity for organosilicon compounds: Exploring and enhancing chemical space boundaries · 2026 · Related
  3. Glucagon-like peptide 1 (GLP-1) · Timo D. Müller · 2019 · 1844 citations · Cited by this paper
  4. Standardization and Assessment of Acute Dermal Toxicity of an Ayurvedic Medicine Brihat Somraji Taila in Sprague-Dawley rats · 2026 · Related
  5. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy · Xi Lu · 2024 · 642 citations · Cited by this paper
  6. Evaluating dosing guidelines for Ginkgo biloba: An evidence-based approach to standardisation · 2026 · Related
  7. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 · Nuha A. ElSayed · 2022 · 480 citations · Cited by this paper
  8. Dietary intake and health risk characterization of cadmium, lead, and mercury in milkfish (Chanos chanos) and tilapia (Oreochromis spp.) from aquaculture farms surrounding Manila bay, Philippines · 2026 · Related
  9. GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects · Xin Zhao · 2021 · 456 citations · Cited by this paper
  10. Polycyclic aromatic hydrocarbon (PAH) contamination in clinical nutrition: Levels and associated health risks in enteral nutrition formulas · 2026 · Related
  11. An update - Prolonging the action of protein and peptide drugs · Shujun Cao · 2020 · 50 citations · Cited by this paper
  12. Automated extraction of toxicological mechanism of action from PubMed literature using Large Language Models · 2026 · Related
  13. Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist · Qinghua Wang · 2010 · 49 citations · Cited by this paper
  14. Derivation of an occupational exposure limit (OEL) for a potent bispecific protein—Blinatumomab (BLINCYTO®) · 2026 · Related
  15. Effect of double antigen bridging immunoassay format on antigen coating concentration dependence and implications for designing immunogenicity assays for monoclonal antibodies · James S. Bourdage · 2005 · 22 citations · Cited by this paper
  16. Microplastics in intravenous fluids: Occurrence, characterization, and risk indicators · 2026 · Related
  17. Population Pharmacokinetics of Efsubaglutide Alfa in Healthy Subjects and Subjects with Type 2 Diabetes · Yan‐Ru Lou · 2025 · 15 citations · Cited by this paper
  18. Food enzyme safety: an extensive lineage of safe Aspergillus niger production strains · 2026 · Related
  19. On the assessment of contamination and analysis of control samples in toxicokinetics studies · Вера Михайловна Косман · 2024 · 2 citations · Cited by this paper
  20. Evaluation of subchronic toxicity, genotoxicity, and blood kinetics of 1,2-benzisothiazolin-3-one following oral administration · 2026 · Related
  21. Untitled · Cited by this paper

Source: OpenAlex (CC0)